亞太地區生物製造中的病毒檢測與定量市場:分析與預測(2023-2032)
市場調查報告書
商品編碼
1420800

亞太地區生物製造中的病毒檢測與定量市場:分析與預測(2023-2032)

Asia-Pacific Biomanufacturing Viral Detection and Quantification Market: Analysis and Forecast, 2023-2032

出版日期: | 出版商: BIS Research | 英文 94 Pages | 商品交期: 1-5個工作天內

價格

亞太地區生物製造中的病毒檢測和定量市場:簡介

主要市場統計資料
預測期 2023-2032
2023年評估 1.1億美元
2032年預測 2.8億美元
年複合成長率 10.47%

亞太地區生物製造中的病毒檢測和定量市場規模預計將從2023年的 1.1 億美元成長到2032年的 2.8 億美元,預計在預測期內年複合成長率為 10.47%。

市場的成長預計將受到生物製藥使用的增加和行業病毒檢測技術的進步的推動。

亞太地區生物製造病毒檢測和定量市場目前快速發展。該成長歸因於該地區生物製藥的採用增加。為了確保生物製藥的安全性、有效性和一致性,對穩健的品管流程的嚴格需求推動對用於量化生技藥品製造中病毒污染物的消耗品和設備的需求。隨著亞太地區生物製藥產業的進步,對病毒檢測和定量解決方案的需求預計將激增。

本報告調查了亞太地區生物製造中病毒檢測和定量的市場,並提供了市場概況、市場成長的各種影響因素分析、法律制度、市場規模趨勢和預測以及主要國家的詳細分析,主要企業分析等總結。

市場分類

細分 1:依產品類型

  • 消耗品
  • 裝置
  • 服務

細分 2:依技術分類

  • PCR法
  • 酵素連結免疫吸附法
  • 流式細胞技術
  • 斑塊測定
  • 其他

細分3:依用途

  • 血液及血液製品製造
  • 疫苗及治療藥物製造
  • 細胞/基因治療產品製造
  • 幹細胞產品製造
  • 紙巾和紙巾產品製造

細分 4:依最終使用者分類

  • 生命科學公司
  • 檢測機構
  • CRO 和 CDMO

細分 5:依國家/地區分類

  • 中國
  • 日本
  • 韓國
  • 澳洲
  • 印度
  • 其他

目錄

執行摘要

第1章 市場範圍

第2章 調查方法

第3章 市場概況

  • 概述
  • 當前市場規模及未來成長潛力

第4章 行業展望

  • 監管狀況

第5章 生物製造中的病毒檢測與定量市場:市場動態

  • 業務促進因素
    • 擴大生物製藥的用途
    • 病毒檢測和定量的技術進步
    • 影響分析
  • 業務限制
    • 先進病毒檢測及定量設備高成本
    • 缺乏病毒檢測和定量領域訓練有素的專業人員
    • 影響分析
  • 商業機會
    • 在細胞和基因治療的開發中越來越需要考慮病毒污染

第6章 生物製造市場中的病毒檢測和定量:依地區

  • 概述
  • 亞太地區
    • 依提供類型
    • 依技術
    • 依用途
    • 依最終用戶
    • 依國家/地區

第7章 市場:競爭基準化分析/公司簡介

  • 概述
  • 企業市場占有率分析
  • 活躍在生態系中的公司
  • TAKARA HOLDINGS INC.
Product Code: BHL1845SS

“The Asia-Pacific Biomanufacturing Viral Detection and Quantification Market Expected to Reach $0.28 Billion by 2032.”

Introduction to Asia-Pacific Biomanufacturing Viral Detection and Quantification Market

KEY MARKET STATISTICS
Forecast Period2023 - 2032
2023 Evaluation$0.11 Billion
2032 Forecast$0.28 Billion
CAGR10.47%

The Asia-Pacific biomanufacturing viral detection and quantification market was valued at $0.11 billion in 2023 and is anticipated to reach $0.28 billion by 2032, witnessing a CAGR of 10.47% during the forecast period 2023-2032. The biomanufacturing viral detection and quantification market growth is anticipated to be propelled by the increasing use of biopharmaceutical products and the technological advancements in viral testing within the industry.

Market Introduction

The Asia-Pacific (APAC) biomanufacturing viral detection and quantification market is currently advancing at a rapid pace. This growth can be attributed to the increasing adoption of biopharmaceuticals within the region. The stringent need for robust quality control processes to ensure the safety, efficacy, and consistency of biopharmaceutical products is driving the demand for consumables and instruments used in quantifying viral contaminants during the biomanufacturing of biologics. As APAC embraces the biopharmaceutical industry's advancements, the demand for viral detection and quantification solutions is expected to surge. This presents a significant opportunity for manufacturers and providers of biomanufacturing viral detection and quantification products in the APAC market, as they play a pivotal role in ensuring the integrity and safety of biopharmaceutical production processes in the region.

Market Segmentation:

Segmentation 1: by Offering Type

  • Consumables
  • Instruments
  • Services

Segmentation 2: by Technology

  • PCR
  • ELISA
  • Flow Cytometry
  • Plaque Assay
  • Others

Segmentation 3: by Application

  • Blood and Blood Products Manufacturing
  • Vaccines and Therapeutics Manufacturing
  • Cellular and Gene Therapy Products Manufacturing
  • Stem Cell Products Manufacturing
  • Tissue and Tissue Products Manufacturing

Segmentation 4: by End User

  • Life Science Companies
  • Testing Laboratories
  • CROs and CDMOs

Segmentation 5: by Country

  • China
  • Japan
  • South Korea
  • Australia
  • India
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.

Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.

Competitive Strategy: Key players in the APAC biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the APAC biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Table of Contents

Executive Summary

1. Market Scope

  • 1.1. Key Questions Answered in the Report

2. Research Methodology

3. Market Overview

  • 3.1. Overview
  • 3.2. Current Market Size and Future Growth Potential, $Billion, 2022-2032

4. Industry Outlook

  • 4.1. Regulatory Landscape
    • 4.1.1. Legal Requirements and Frameworks in Asia-Pacific
      • 4.1.1.1. Legal Requirements and Framework in Japan

5. Biomanufacturing Viral Detection and Quantification Market: Market Dynamics

  • 5.1. Business Drivers
    • 5.1.1. Increasing Utilization of Biopharmaceuticals
    • 5.1.2. Technological Advancements in Viral Detection and Quantification
    • 5.1.3. Impact Analysis
  • 5.2. Business Restraints
    • 5.2.1. High Cost of Advanced Viral Detection and Quantification Equipment
    • 5.2.2. Lack of Trained Professionals in the Field of Viral Detection and Quantification
    • 5.2.3. Impact Analysis
  • 5.3. Business Opportunities
    • 5.3.1. Increasing Need in Viral Contamination Considerations for the Development of Cell and Gene Therapies

6. Biomanufacturing Viral Detection and Quantification Market (by Region), Value ($Million), 2022-2032

  • 6.1. Overview
  • 6.2. Asia-Pacific
    • 6.2.1. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    • 6.2.2. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
    • 6.2.3. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
    • 6.2.4. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Country)
      • 6.2.5.1. China
        • 6.2.5.1.1. China Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 6.2.5.1.2. China Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 6.2.5.1.3. China Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 6.2.5.1.4. China Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 6.2.5.2. Japan
        • 6.2.5.2.1. Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 6.2.5.2.2. Japan Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 6.2.5.2.3. Japan Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 6.2.5.2.4. Japan Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 6.2.5.3. India
        • 6.2.5.3.1. India Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 6.2.5.3.2. India Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 6.2.5.3.3. India Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 6.2.5.3.4. India Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 6.2.5.4. Australia
        • 6.2.5.4.1. Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 6.2.5.4.2. Australia Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 6.2.5.4.3. Australia Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 6.2.5.4.4. Australia Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 6.2.5.5. South Korea
        • 6.2.5.5.1. South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 6.2.5.5.2. South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 6.2.5.5.3. South Korea Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 6.2.5.5.4. South Korea Biomanufacturing Viral Detection and Quantification Market (by End User)
      • 6.2.5.6. Rest-of-Asia-Pacific
        • 6.2.5.6.1. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
        • 6.2.5.6.2. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
        • 6.2.5.6.3. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
        • 6.2.5.6.4. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)

7. Markets - Competitive Benchmarking & Company Profiles

  • 7.1. Overview
  • 7.2. Company Share Analysis
  • 7.3. Biomanufacturing Viral Detection and Quantification Ecosystem Active Players
  • 7.4. TAKARA HOLDINGS INC.
    • 7.4.1. Company Overview
    • 7.4.2. Role of TAKARA HOLDINGS INC. in the Biomanufacturing Viral Detection and Quantification Market
    • 7.4.3. Key Competitors
    • 7.4.4. Financials
    • 7.4.5. Key Insights about the Financial Health of the Company
    • 7.4.6. Analyst Perspective

List of Figures

  • Figure 1: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
  • Figure 2: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market: Drivers, Restraints, and Opportunities
  • Figure 3: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Billion, 2022-2032
  • Figure 4: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Billion, 2022-2032
  • Figure 5: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Billion, 2022-2032
  • Figure 6: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market: Research Methodology
  • Figure 7: Primary Research Methodology
  • Figure 8: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 9: Top-Down Approach (Segment-Wise Analysis)
  • Figure 10: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
  • Figure 11: Biomanufacturing Viral Detection and Quantification Market (by Region)
  • Figure 12: Measures Undertaken by APAC to Enhance its Viral Testing Capacity
  • Figure 13: Asia-Pacific: Market Dynamics
  • Figure 14: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
  • Figure 15: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 16: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 17: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 18: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 19: China Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 20: China Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 21: China Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 22: China Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 23: China Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 24: Japan Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 25: Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 26: Japan Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 27: Japan Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 28: Japan Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 29: India Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 30: India Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 31: India Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 32: India Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 33: India Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 34: Australia Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 35: Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 36: Australia Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 37: Australia Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 38: Australia Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 39: South Korea Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 40: South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 41: South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 42: South Korea Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 43: South Korea Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 44: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
  • Figure 45: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
  • Figure 46: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
  • Figure 47: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
  • Figure 48: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
  • Figure 49: Biomanufacturing Viral Detection and Quantification Market, Total Number of Companies Profiled
  • Figure 50: Biomanufacturing Viral Detection and Quantification Market, Company Share Analysis, % Share, 2022
  • Figure 51: TAKARA HOLDINGS INC.: Product Portfolio
  • Figure 52: TAKARA HOLDINGS INC.: Overall Financials, $Million, 2020-2022
  • Figure 53: TAKARA HOLDINGS INC.: Revenue (by Region), $Million, 2020-2022
  • Figure 54: TAKARA HOLDINGS INC.: R&D Expenditure, $Million, 2020-2022

List of Tables

  • Table 1: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, Impact Analysis
  • Table 2: Key Questions Answered in the Report
  • Table 3: Methods of Virus Detection and Quantification
  • Table 4: Biomanufacturing Viral Detection and Quantification Market: Regulatory Scenario
  • Table 5: Technological Advancement in the Field of Viral Testing
  • Table 6: Impact Analysis: Business Drivers
  • Table 7: Impact Analysis: Business Restraints